FERRARA, F. Antirheumatic in SARS-CoV-2: benefit or risk?. Italian Journal of Medicine, [S. l.], v. 14, n. 2, p. 114–115, 2020. DOI: 10.4081/itjm.2020.1290. Disponível em: https://www.italjmed.org/ijm/article/view/itjm.2020.1290. Acesso em: 26 apr. 2024.